Brief: Samsung Epis Holdings Says Unit Samsung Bioepis Entered Into Exclusive Supply Agreement Under Brazilian Government Programme For Rare-Disease TreatmentYesterday 02:50
Brief: Samsung Bioepis, Teva Expand Strategic Partnership To Advance Up To 6 Potential Biosimilar Candidates01/10/2026 09:45
Brief: Samsung Epis Holdings Co Applies To Korea Food Ministry For Approval Of Pembrolizumab Biosimilar10/08/2026 09:05